1. Department of Medicine A, Translational Oncology, Albert-Schweitzer Campus 1, University Hospital Münster, Münster, Germany;
2. Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany;
3. Cells in Motion Cluster of Excellence, Münster, Germany;
4. Mathematisch-Naturwissenschaftliche Fakultät I, Humboldt University Berlin, Berlin, Germany;
5. Department of Physics, Philipps-University, Marburg, Germany;
6. Department of Experimental Pathology, Medical University Vienna, Wien, Austria;
7. Department of Molecular Biology and Genetics, Boğaziçi University, Bebek, Istanbul, Turkey;
8. Institute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany;
9. Experimental Pharmacology & Oncology Berlin-Buch GmbH, Berlin, Germany;
10. Max-Delbrück-Center for Molecular Medicine, Berlin, Germany;
11. Institute of Pathology, University Hospital, Basel, Switzerland;
12. Department of Pathology, University of Würzburg, Würzburg, Germany; and
13. Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany